Vifor Pharma

Activities: Manufacturing

Trending Articles

  1. ReciBioPharm attains Bill & Melinda Gates Foundation grant to achieve continuous RNA manufacturing The biologics CDMO hopes to bring RNA medicines to more patients globally by providing its xRNA continuous manufacturing technology to lower and middle income countries
  2. Arterex completes acquisition of medical device manufacturer Phoenix The medical device specialist will have access to Phoenix's Modena facility, which has four ISO 8 cleanrooms for sterile assembly and packaging and 37,000 sqft of manufacturing...
  3. C.P.M. Contractpharma GmbH and Co. KG
  4. Broughton welcomes FDA authorisation of ZYN Nicotine Pouches Broughton welcomes the US Food and Drug Administration’s (FDA) decision to authorise ZYN nicotine pouches for sale
  5. Gerresheimer & Bormioli Pharma make their first joint trade show appearance at Pharmapack 2025 The companies will showcase their containment and primary packaging solutions, as well as their digital and drug delivery systems for the pharmaceutical market

Upcoming event

Pharma Packaging and Labelling Forum

5–6 March 2025 | Conference | San Diego, US See all

Related Content

Finance

Vifor Pharma to propose Åsa Riisberg for board of directors

Riisberg holds a MSc in Financial Economics and Business Administration from Stockholm School of Economics
Ingredients

Vifor Pharma enters Chinese joint venture with Fresenius Kabi

Joint venture will bring IV Iron to China to replace the wasteful blood transfusions that are the current prevailing treatment for iron deficiency anaemia
Finance

Vifor Pharma enters commercial diabetes collaboration in the US

The Swiss pharma company will work with US-based Janssen to jointly commercialise INVOKANA (canagliflozin) in the US to address complications of type 2 diabetes
Drug Delivery

PIVOTAL trial confirms long-term safety and efficacy of IV iron dosing

The long-term safety and efficacy of intravenous iron dosing has been confirmed allowing higher Ferritin concentration and transferrin saturation in patients undergoing haemodialysis
Recruitment

Vifor pharma announces management changes
Media

Vifor Pharma proposes Jacques Theurillat as board member
Pharmaceutical

Kissei to market Avacopan in Japan for Vifor Pharma

Vifor Fresenius Medical Care Renal Pharma has granted Japanese pharmaceutical company, Kissei, exclusive rights to develop and commercialise Avacopan in Japan
Subscribe now